Sherwood S W, Schumacher R I, Schimke R T
Department of Biological Sciences, Stanford University, California 94305.
Mol Cell Biol. 1988 Jul;8(7):2822-7. doi: 10.1128/mcb.8.7.2822-2827.1988.
We examined the effects of 18 h of incubation of Chinese hamster ovary (CHO K1) cells with cycloheximide, hydroxyurea, and aphidicolin. Treatment of cells with cycloheximide alone at a concentration adequate to inhibit DNA synthesis to less than 10% of control was significantly less cytotoxic and clastogenic than treatment with hydroxyurea or aphidicolin, did not induce unbalanced cellular growth, and had no effect on the frequency of resistant cells in methotrexate selections compared with control cells. When combined with hydroxyurea or aphidicolin and compared with the effects of either drug alone, cycloheximide blocked the induction of unbalanced growth during drug treatment, reduced the frequency of chromosomal aberrations in recovering cell populations, and decreased cell killing. In addition, the increased frequency of methotrexate-resistant cells observed after treatment with hydroxyurea or aphidicolin was eliminated when cycloheximide was present during drug treatment.
我们研究了用放线菌酮、羟基脲和阿非迪霉素对中国仓鼠卵巢(CHO K1)细胞进行18小时孵育的效果。用足以将DNA合成抑制至对照水平10%以下的浓度的放线菌酮单独处理细胞,其细胞毒性和致断裂性明显低于用羟基脲或阿非迪霉素处理,不会诱导细胞生长失衡,并且与对照细胞相比,对甲氨蝶呤选择中耐药细胞的频率没有影响。当与羟基脲或阿非迪霉素联合使用并与单独使用任一药物的效果进行比较时,放线菌酮在药物处理期间阻止了生长失衡的诱导,降低了恢复细胞群体中染色体畸变的频率,并减少了细胞杀伤。此外,当药物处理期间存在放线菌酮时,用羟基脲或阿非迪霉素处理后观察到的甲氨蝶呤耐药细胞频率增加的情况被消除。